Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region - Global Forecast to 2027
The global healthcare interoperability solutions market is projected to reach USD 6.2 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 12.9% during the forecast period. Growth in this market is driven by the increased demand for efficient & cost-effective healthcare delivery, government funding for healthcare interoperability, and the rapid adoption of EHR. However, the lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.
“HIE Interoperability Solutions was the fastest-growing segment in the type of healthcare interoperability solutions market for software solutions in 2021”
HIE Interoperability Solutions accounted for the largest share of healthcare interoperability solutions market for software solutions in 2021. The large share of this segment can be attributed to the associated benefits such as improved patient safety by reducing medication and medical errors, increased efficiency by eliminating unnecessary paperwork and handling, as well as providing caregivers with clinical decision support tools for more effective care and treatment.
“Foundational Interoperability accounted for the largest segment by level of interoperaility in the healthcare interoperability solutions market in 2021”
Based on the level of interoperability, the foundational interoperability segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of the foundational interoperability segment can be attributed to the need for safe and accurate data exchange across disparate systems as well as the growing demand for cost-effective basic-level interoperability.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives to unfold new national interoperability policies and rework existing policies with public and private healthcare organizations, growing medical tourism, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.
The break-down of primary participants is as mentioned below:
The key players operating in the healthcare interoperability solutions market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).
Research Coverage:
The report analyzes the healthcare interoperability solutions market and aims at estimating the market size and future growth potential of various market segments, based on type, level of interoperability, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
“HIE Interoperability Solutions was the fastest-growing segment in the type of healthcare interoperability solutions market for software solutions in 2021”
HIE Interoperability Solutions accounted for the largest share of healthcare interoperability solutions market for software solutions in 2021. The large share of this segment can be attributed to the associated benefits such as improved patient safety by reducing medication and medical errors, increased efficiency by eliminating unnecessary paperwork and handling, as well as providing caregivers with clinical decision support tools for more effective care and treatment.
“Foundational Interoperability accounted for the largest segment by level of interoperaility in the healthcare interoperability solutions market in 2021”
Based on the level of interoperability, the foundational interoperability segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of the foundational interoperability segment can be attributed to the need for safe and accurate data exchange across disparate systems as well as the growing demand for cost-effective basic-level interoperability.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives to unfold new national interoperability policies and rework existing policies with public and private healthcare organizations, growing medical tourism, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
- By Designation - C-level: 50%, Director-level: 35%, and Others: 15%
- By Region - North America: 48%, Europe: 32%, Asia Pacific: 15%, and Rest of the World: 5%.
The key players operating in the healthcare interoperability solutions market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).
Research Coverage:
The report analyzes the healthcare interoperability solutions market and aims at estimating the market size and future growth potential of various market segments, based on type, level of interoperability, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (increasing demand for efficient and cost-effective healthcare delivery, government initiatives and regulations to enhance patient care and safety, emergence of new medical technologies, growing adoption of electronic health records), restraints (lack of accurate interoperability solutions across healthcare supply chain, lack of standards and protocols in IT businesses, use of outdated legacy systems in hospitals and clinic chains), opportunities (growing markets for healthcare interoperability solutions in developing countries, advancements in software technology for real-time data exchange),and challenges (increasing complexity due to lack of consistent data, shortage of skilled healthcare IT professionals, patient data security and privacy concerns in healthcare industry)influencing the growth of the healthcare interoperability solutions market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare interoperability solutions market.
- Market Development: Comprehensive information on the lucrative emerging markets, type, level of interoperability, end user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare interoperability solutions market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare interoperability solutions market like Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Insights from primary experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 CAGR PROJECTIONS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
2.2.1 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
2.8 IMPACT OF ECONOMIC RECESSION ON HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
2.8.1 IMPACT OF RUSSIA–UKRAINE WAR
2.8.2 IMPACT OF INFLATION
3 EXECUTIVE SUMMARY
FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION)
FIGURE 10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
4 PREMIUM INSIGHTS
4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW
FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET
4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021)
FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2021
4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2022–2027)
FIGURE 15 NORTH AMERICA TO DOMINATE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET DURING FORECAST PERIOD
4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027
FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery
5.2.1.2 Government initiatives and regulations to enhance patient care and safety
5.2.1.3 Emergence of new medical technologies
5.2.1.4 Growing adoption of electronic health records
5.2.2 RESTRAINTS
5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain
5.2.2.2 Lack of standards and protocols in IT businesses
5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains
5.2.3 OPPORTUNITIES
5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries
5.2.3.2 Advancements in software technology for real-time data exchange
5.2.4 CHALLENGES
5.2.4.1 Increasing complexity due to lack of consistent data
5.2.4.2 Shortage of skilled healthcare IT professionals
5.2.4.3 Patient data security and privacy concerns in healthcare industry
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
5.5 ECOSYSTEM ANALYSIS
FIGURE 19 ECOSYSTEM ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
5.6 TECHNOLOGY ANALYSIS
5.6.1 APPLICATION PROGRAMMING INTERFACES
5.6.2 CLOUD-BASED SOLUTIONS
5.6.3 BLOCKCHAIN TECHNOLOGY
5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES
5.6.5 ARTIFICIAL INTELLIGENCE
5.6.6 MACHINE LEARNING
5.7 KEY CONFERENCES AND EVENTS IN 2023
TABLE 2 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2 LAWS, REGULATIONS, AND STANDARDS
TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY
5.9 PORTER'S FIVE FORCES ANALYSIS
FIGURE 20 PORTER’S FIVE FORCES ANALYSIS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
5.10.2 BUYING CRITERIA
FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 11 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 SOFTWARE SOLUTIONS
TABLE 12 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 EHR INTEROPERABILITY SOLUTIONS
6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians
TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS
6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market
TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS
6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market
TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 HIE INTEROPERABILITY SOLUTIONS
6.2.4.1 Large investments by federal governments to propel market
TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS
6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market
TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS
TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 25 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SERVICES
6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET
TABLE 26 SERVICES OFFERED BY KEY PLAYERS
TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL
7.1 INTRODUCTION
TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
7.2 FOUNDATIONAL INTEROPERABILITY
7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET
TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 STRUCTURAL INTEROPERABILITY
7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL
TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 SEMANTIC INTEROPERABILITY
7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HEALTHCARE PROVIDERS
TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 HOSPITALS & CLINICS
8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market
TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 LONG-TERM CARE CENTERS
8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market
TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3 DIAGNOSTIC & IMAGING CENTERS
8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market
TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.4 OTHER HEALTHCARE PROVIDERS
TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HEALTHCARE PAYERS
8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS
TABLE 39 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 PHARMACIES
8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT
TABLE 40 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 41 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Growing need to curtail healthcare costs to drive market
TABLE 48 US: KEY MACROINDICATORS
TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 52 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 53 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing healthcare digitization to support market
TABLE 54 CANADA: KEY MACROINDICATORS
TABLE 55 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 58 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 59 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market
TABLE 66 GERMANY: KEY MACROINDICATORS
TABLE 67 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Government initiatives and NHS programs to drive demand
TABLE 72 UK: KEY MACROINDICATORS
TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 76 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 77 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government measures to curtail healthcare expenditures to fuel market
TABLE 78 FRANCE: KEY MACROINDICATORS
TABLE 79 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 82 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 83 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market
TABLE 84 ITALY: KEY MACROINDICATORS
TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 88 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 89 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.5 NETHERLANDS
9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market
TABLE 90 NETHERLANDS: KEY MACROINDICATORS
TABLE 91 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 94 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 95 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 99 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 100 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
TABLE 101 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 102 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 105 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 106 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period
TABLE 107 JAPAN: KEY MACROINDICATORS
TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 111 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 112 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4.2 AUSTRALIA
9.4.2.1 Increasing government initiatives for better clinical communication to drive market
TABLE 113 AUSTRALIA: KEY MACROINDICATORS
TABLE 114 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 117 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 118 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 122 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 123 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET
TABLE 124 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 127 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 128 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET
TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 134 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY DEVELOPMENTS (JANUARY 2019–MARCH 2023)
10.3 MARKET RANKING OF KEY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
FIGURE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: MARKET RANKING OF KEY PLAYERS (2022)
10.4 MARKET SHARE ANALYSIS
10.4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 135 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2021
10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022)
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 136 COMPANY PRODUCT FOOTPRINT
10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 137 COMPANY REGION FOOTPRINT
10.7.3 FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 138 COMPANY FOOTPRINT
10.8 COMPETITIVE SCENARIO
10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS
TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019–2022
10.8.2 KEY DEALS
TABLE 140 KEY DEALS, 2019–2022
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*
11.1.1 ORACLE HEALTH
TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW
FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021)
11.1.2 EPIC SYSTEMS CORPORATION
TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
11.1.3 INFOR, INC.
TABLE 143 INFOR, INC.: COMPANY OVERVIEW
FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019)
11.1.4 INTERSYSTEMS CORPORATION
TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW
11.1.5 KONINKLIJKE PHILIPS N.V.
TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
11.1.6 VERADIGM LLC
TABLE 146 VERADIGM LLC: COMPANY OVERVIEW
FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021)
11.1.7 COGNIZANT
TABLE 147 COGNIZANT: COMPANY OVERVIEW
FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021)
11.1.8 CHANGE HEALTHCARE
TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW
FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
11.1.9 NEXTGEN HEALTHCARE, INC.
TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020)
11.1.10 MERATIVE
TABLE 150 MERATIVE: COMPANY OVERVIEW
11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019)
11.1.12 LYNIATE
TABLE 152 LYNIATE: COMPANY OVERVIEW
11.1.13 OSP LABS
TABLE 153 OSP LABS: COMPANY OVERVIEW
11.1.14 ORION HEALTH GROUP OF COMPANIES
TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW
FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021)
11.1.15 ONYX TECHNOLOGY LLC
TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VISOLVE
TABLE 156 VISOLVE: COMPANY OVERVIEW
11.2.2 JITTERBIT
TABLE 157 JITTERBIT: COMPANY OVERVIEW
11.2.3 INTERFACEWARE INC.
TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW
11.2.4 VIRTUSA CORP.
TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW
FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020)
11.2.5 CONSENSUS CLOUD SOLUTIONS INC.
TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW
11.2.6 MPHRX
11.2.7 WIPRO
11.2.8 EMIDS
11.2.9 NALASHAA
11.2.10 DEEVITA LLC
* Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Insights from primary experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 CAGR PROJECTIONS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
2.2.1 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
2.8 IMPACT OF ECONOMIC RECESSION ON HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
2.8.1 IMPACT OF RUSSIA–UKRAINE WAR
2.8.2 IMPACT OF INFLATION
3 EXECUTIVE SUMMARY
FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION)
FIGURE 10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
4 PREMIUM INSIGHTS
4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW
FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET
4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021)
FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2021
4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2022–2027)
FIGURE 15 NORTH AMERICA TO DOMINATE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET DURING FORECAST PERIOD
4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027
FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery
5.2.1.2 Government initiatives and regulations to enhance patient care and safety
5.2.1.3 Emergence of new medical technologies
5.2.1.4 Growing adoption of electronic health records
5.2.2 RESTRAINTS
5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain
5.2.2.2 Lack of standards and protocols in IT businesses
5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains
5.2.3 OPPORTUNITIES
5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries
5.2.3.2 Advancements in software technology for real-time data exchange
5.2.4 CHALLENGES
5.2.4.1 Increasing complexity due to lack of consistent data
5.2.4.2 Shortage of skilled healthcare IT professionals
5.2.4.3 Patient data security and privacy concerns in healthcare industry
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
5.5 ECOSYSTEM ANALYSIS
FIGURE 19 ECOSYSTEM ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
5.6 TECHNOLOGY ANALYSIS
5.6.1 APPLICATION PROGRAMMING INTERFACES
5.6.2 CLOUD-BASED SOLUTIONS
5.6.3 BLOCKCHAIN TECHNOLOGY
5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES
5.6.5 ARTIFICIAL INTELLIGENCE
5.6.6 MACHINE LEARNING
5.7 KEY CONFERENCES AND EVENTS IN 2023
TABLE 2 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2 LAWS, REGULATIONS, AND STANDARDS
TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY
5.9 PORTER'S FIVE FORCES ANALYSIS
FIGURE 20 PORTER’S FIVE FORCES ANALYSIS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
5.10.2 BUYING CRITERIA
FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 11 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 SOFTWARE SOLUTIONS
TABLE 12 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 EHR INTEROPERABILITY SOLUTIONS
6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians
TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS
6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market
TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS
6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market
TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 HIE INTEROPERABILITY SOLUTIONS
6.2.4.1 Large investments by federal governments to propel market
TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS
6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market
TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS
TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
TABLE 25 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SERVICES
6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET
TABLE 26 SERVICES OFFERED BY KEY PLAYERS
TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL
7.1 INTRODUCTION
TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
7.2 FOUNDATIONAL INTEROPERABILITY
7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET
TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 STRUCTURAL INTEROPERABILITY
7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL
TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 SEMANTIC INTEROPERABILITY
7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HEALTHCARE PROVIDERS
TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 HOSPITALS & CLINICS
8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market
TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 LONG-TERM CARE CENTERS
8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market
TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3 DIAGNOSTIC & IMAGING CENTERS
8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market
TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.4 OTHER HEALTHCARE PROVIDERS
TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HEALTHCARE PAYERS
8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS
TABLE 39 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 PHARMACIES
8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT
TABLE 40 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 41 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Growing need to curtail healthcare costs to drive market
TABLE 48 US: KEY MACROINDICATORS
TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 52 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 53 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing healthcare digitization to support market
TABLE 54 CANADA: KEY MACROINDICATORS
TABLE 55 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 58 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 59 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market
TABLE 66 GERMANY: KEY MACROINDICATORS
TABLE 67 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Government initiatives and NHS programs to drive demand
TABLE 72 UK: KEY MACROINDICATORS
TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 76 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 77 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government measures to curtail healthcare expenditures to fuel market
TABLE 78 FRANCE: KEY MACROINDICATORS
TABLE 79 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 82 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 83 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market
TABLE 84 ITALY: KEY MACROINDICATORS
TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 88 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 89 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.5 NETHERLANDS
9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market
TABLE 90 NETHERLANDS: KEY MACROINDICATORS
TABLE 91 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 94 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 95 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 99 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 100 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
TABLE 101 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 102 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 105 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 106 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period
TABLE 107 JAPAN: KEY MACROINDICATORS
TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 111 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 112 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4.2 AUSTRALIA
9.4.2.1 Increasing government initiatives for better clinical communication to drive market
TABLE 113 AUSTRALIA: KEY MACROINDICATORS
TABLE 114 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 117 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 118 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 122 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 123 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET
TABLE 124 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 127 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 128 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET
TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 134 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY DEVELOPMENTS (JANUARY 2019–MARCH 2023)
10.3 MARKET RANKING OF KEY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
FIGURE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: MARKET RANKING OF KEY PLAYERS (2022)
10.4 MARKET SHARE ANALYSIS
10.4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 135 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2021
10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022)
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 136 COMPANY PRODUCT FOOTPRINT
10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 137 COMPANY REGION FOOTPRINT
10.7.3 FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
TABLE 138 COMPANY FOOTPRINT
10.8 COMPETITIVE SCENARIO
10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS
TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019–2022
10.8.2 KEY DEALS
TABLE 140 KEY DEALS, 2019–2022
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*
11.1.1 ORACLE HEALTH
TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW
FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021)
11.1.2 EPIC SYSTEMS CORPORATION
TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
11.1.3 INFOR, INC.
TABLE 143 INFOR, INC.: COMPANY OVERVIEW
FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019)
11.1.4 INTERSYSTEMS CORPORATION
TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW
11.1.5 KONINKLIJKE PHILIPS N.V.
TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
11.1.6 VERADIGM LLC
TABLE 146 VERADIGM LLC: COMPANY OVERVIEW
FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021)
11.1.7 COGNIZANT
TABLE 147 COGNIZANT: COMPANY OVERVIEW
FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021)
11.1.8 CHANGE HEALTHCARE
TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW
FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
11.1.9 NEXTGEN HEALTHCARE, INC.
TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020)
11.1.10 MERATIVE
TABLE 150 MERATIVE: COMPANY OVERVIEW
11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019)
11.1.12 LYNIATE
TABLE 152 LYNIATE: COMPANY OVERVIEW
11.1.13 OSP LABS
TABLE 153 OSP LABS: COMPANY OVERVIEW
11.1.14 ORION HEALTH GROUP OF COMPANIES
TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW
FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021)
11.1.15 ONYX TECHNOLOGY LLC
TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VISOLVE
TABLE 156 VISOLVE: COMPANY OVERVIEW
11.2.2 JITTERBIT
TABLE 157 JITTERBIT: COMPANY OVERVIEW
11.2.3 INTERFACEWARE INC.
TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW
11.2.4 VIRTUSA CORP.
TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW
FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020)
11.2.5 CONSENSUS CLOUD SOLUTIONS INC.
TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW
11.2.6 MPHRX
11.2.7 WIPRO
11.2.8 EMIDS
11.2.9 NALASHAA
11.2.10 DEEVITA LLC
* Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
